Ozempic vs Mounjaro: Which Is Better for Weight Loss? (2026)
How they differ
Which works better?
The evidence leans toward tirzepatide for weight loss. In a large real-world analysis, people on tirzepatide were about three times more likely to reach 15% weight loss than those on semaglutide, and roughly 82% hit at least 5% loss within a year versus about 67% on semaglutide. In trials, tirzepatide produced around 20%+ body-weight reduction versus about 15% for semaglutide.
That doesn't make semaglutide a bad choice — it's highly effective, more widely available, comes in an oral form, and may be cheaper or better covered depending on your insurance.
Side effects
Both cause similar gastrointestinal side effects — nausea, diarrhea, constipation — usually worst early and easing over time. Some data suggest tirzepatide may be slightly better tolerated, but individual responses vary. Both carry rare but serious risks and require a prescription.
Brand-name confusion, cleared up
It's easy to get lost in the names: Ozempic and Wegovy are both semaglutide (diabetes vs weight-loss versions). Mounjaro and Zepbound are both tirzepatide (diabetes vs weight-loss versions). We unpack the semaglutide pair in Ozempic vs Wegovy.

Best GLP-1 Telehealth Programs of 2026
The top online programs for semaglutide and tirzepatide, compared on price and safety.

Ozempic vs Wegovy (2026)
Same drug, different dose — which semaglutide version is for weight loss.